Erratum: Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users (Journal of Psychopharmacology 27 (497-506) DOI: 10.1177/0269881113477744);Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users

Journal of Psychopharmacology

Volumn 27, Issue 6, 2013, Pages 497-506

  Morgan, Celia J A ^a   Noronha, Louise A ^a   Muetzelfeldt, Mark ^a   Fielding, Amanda ^b   Curran, H Valerie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b THE BECKLEY FOUNDATION   (United Kingdom)

Author keywords

Alcohol; benefits; cannabis; drug abuse; ecstasy; harms; legal status

Indexed keywords

ALCOHOL; AMPHETAMINE; ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; KETAMINE; NARCOTIC ANALGESIC AGENT; NITROUS OXIDE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SILDENAFIL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DRUG ABUSE; DRUG CHOICE; DRUG DEPENDENCE; DRUG MISUSE; FEMALE; HEALTH SURVEY; HUMAN; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TOBACCO;

EID: 84878072968     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115598040     Document Type: Erratum

References (37)

1. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: Criterion validity in a primary care practice. Wis Med J. 1995 ; 94: 135-140
2. Carhart-Harris RL. A web based survey on mephedrone. Drug Alcohol Depend. 2011 ; 118: 19-22
3. Carhart-Harris RL, Nutt DJ. User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. J Subst Use. 2010 ; 15: 283-300
4. Caulkins J, Reuter P, Coulson C. Basing drug scheduling decisions on scientific ranking of harmfulness: False promise from false premises. Addiction. 2011 ; 106: 1886-1890
5. Centre for Disease Control and Prevention (2011) Vital signs: Overdoses of prescription opioid pain relievers - United States, 1999-2008. Available at: http://www.cdc.gov/vitalsigns (accessed 5 February 2012).
6. Cohen P. The concept of 'drug harms'. Drug Alcohol Today. 2010 ; 10: 10-12
7. Coulson C, Caulkins J. Scheduling of newly emerging drugs: A critical review of decisions over 40 years. Addiction. 2012 ; 107: 766-773
8. Di Forti M, Morgan C, Dazzan P, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry. 2009 ; 195: 488-491
9. Fischer B, Kendall P. Nutt et al's harm scales for drugs - Room for improvement but better policy based on science with limitations than no science at all. Addiction. 2011 ; 106: 1891-1892
10. Griffiths R, Johnson W, Richards W, et al. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology. 2011 ; 218: 649-665
11. Griffiths R, Richards W, Johnson W, et al. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol. 2008 ; 22: 621-632
12. Griffiths R, Richards W, McCann U, et al. Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006 ; 187: 268-283
13. Johansen P, Krebs T. How could ecstasy help anxiety disorders? A neurobiological rationale. J Psychopharmacol. 2009 ; 23: 389
14. Kalant H. Drug classification: science, politics, both or neither?. Addiction. 2010 ; 105: 1146-1149
15. Krebs T, Johansen P. Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. J Psychopharmacol. 2012 ; 26: 994-1002
16. Krupitsky E, Burakov A, Romanova T. Ketamine psychotherapy for heroin addiction. J Subst Abuse Treat. 2002 ; 23: 273-283
17. Mackay J, Eriksen M, Shafey O The Tobacco Atlas. 2006 ) The Tobacco Atlas, 2nd Edition.Atlanta, GA: American Cancer Society. Atlanta, GA: American Cancer Society ; 2006 :
18. Mithoefer M. MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD): Ninth update on study progress. MAPS Bull. 2006 ; 16: 14-15
19. Morgan CJ, Curran HV. Ketamine use: a review. Addiction. 2011 ; 107: 27-38
20. Morgan CJA, Freeman TP, Schafer GL, et al. Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology. 2010a ; 35: 1879-1885
21. Morgan CJ, Muetzelfeldt L, Muetzelfeldt M, et al. Harms associated with psychoactive substances: Findings of the UK National Drug Survey. J Psychopharmacol. 2010b ; 24: 147-153
22. Morgan CJA, Schafer G, Freeman TP, et al. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study. Br J Psychiatry. 2010c ; 197: 285-290
23. Móró L, Noreika V. Sacramental and spiritual use of hallucinogenic drugs. Behav Brain Sci. 2011 ; 34: 319-320
24. Müller C, Schumann G. Drugs as instruments: A new framework for non-addictive psychoactive drug use. Behav Brain Sci. 2011 ; 34: 293-347
25. Nutt D, King LA, Saulsbury W, et al. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007 ; 369: 1047-1053
26. Nutt DJ, King LA, Philips LD. Drug harms in the UK: A multicriteria decision analysis. Lancet. 2010 ; 376: 1558-1565
27. Obot I. Improved ranking of drugs on harmfulness can bring sense and order to a failed system. Addiction. 2011 ; 106: 1894-1895
28. Room R, Lubman DI. Politics and science in classifying the dangers of drugs. Evid Based Ment Health. 2010 ; 13: 97-99
29. Sessa B. Can psychedelics have a role in psychiatry once again?. Br J Psychiatry. 2005 ; 186: 456-457
30. Sessa B. Is there a case for MDMA-assisted psychotherapy in the UK?. J Psychopharmacol. 2007 ; 21: 220-224
31. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration ; 2011 :
32. Tart C On Being Stoned: A Psychological Study of Marijuana Intoxication. Palo Alto: Science and Behavior Books ; 1971 :
33. World Drug Report (2010). Vienna: United Nations ; 2010 :
34. National Drug Threat Assessment- Executive Summary. Washington, DC: US Department of Justice National Drugs Intelligence Centre ; 2011 :
35. van Amsterdam J, Opperhuizen A, Koeter M, et al. Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res. 2010 ; 16: 202-207
36. Walton R Marihuana. America's New Drug Problem. New York: JB Lippincott ; 1938 :
37. Global Status Report on Alcohol and Health. Geneva, Switzerland: WHO ; 2011 :